TRAW Dividend: Traws Pharma Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

TRAW Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	2	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--
Cost of Revenue	--	--	--	--	--
Gross Profit	--	--	--	--	--
Selling, General & Admin	11	12	9	8	9
Research & Development	11	12	11	11	7
Operating Expenses	23	25	20	19	16
Other Non Operating Income (Expenses)	2	-24	0	0	0
Pretax Income	-17	-166	-18	-18	-16
Income Tax Expense	--	--	--	--	0
Net Income	87	-54	-18	-18	-16
Net Income Growth	-164%	200%	0%	13%	--
Shares Outstanding (Diluted)	5.82	1.55	0.83	0.83	0.67
Shares Change (YoY)	475%	85%	0%	24%	--
EPS (Diluted)	15.1	-35.21	-22.56	-22.67	-24
EPS Growth	-111%	56%	0%	-6%	--
Free Cash Flow	-26	-29	-17	-16	-19
Free Cash Flow Per Share	-4.46	-18.67	-20.24	-19.13	-28.21
Gross Margin	--	--	--	--	--
Operating Margin	-1,000%	0%	0%	0%	0%
Profit Margin	4,350%	0%	0%	0%	0%
Free Cash Flow Margin	-1,300%	0%	0%	0%	0%
EBITDA	-20	-24	-20	-19	-16
EBITDA Margin	-1,000%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0
EBIT	-20	-24	-20	-19	-16
EBIT Margin	-1,000%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	0%